The important question around this compounding pharmacy is practical: what is actually known, what remains uncertain, and what safeguards a licensed clinician and pharmacy process add before anyone treats it as an option.
I was six minutes into my usual Thursday run along Lake Merritt in Oakland when I realized something was wrong. My Garmin read a 9:42 pace, a full forty seconds slower than normal, and my heart rate was already at 162. I’d been on compounded semaglutide for three weeks. My friend Marcus, who runs that loop with me, looked over and said, “You good? You look like you’re running uphill.” I wasn’t good. I walked the last mile home and spent the rest of the evening trying to figure out what had happened to my body.
The exercise routine that fit me before the medication did not fit me after. And the changes weren’t the ones I expected.
I had assumed the medication would make exercise easier. Less weight to move, right? Simple physics. The actual changes were more subtle and, honestly, more interesting, and they took about four months to sort out. What follows is the patient-level account of what shifted, what the clinical literature says about exercise on GLP-1 therapy, and the routine that ended up working once things stabilized.
Compounded semaglutide is not FDA-approved. It is prepared by licensed compounding pharmacies for individual patients under a prescriber’s order. The clinical literature on the branded products is the strongest available reference for the medication’s effects, and the exercise patterns described here are broadly consistent with that literature.
The First Month Felt Like Starting Over
That Lake Merritt run wasn’t a fluke. For the entire first month, my cardiovascular capacity during steady-state work dropped noticeably. Same pace, higher heart rate. Same intervals, longer recovery. It felt like I’d lost three months of fitness overnight.
Here’s the thing: it wasn’t really a fitness loss. It was a fueling problem. I talked to my prescriber and did some reading, and the picture came together. The reduced food intake had cut my immediately available glucose. I was mildly dehydrated because the medication had blunted my thirst along with my appetite. Some patients on GLP-1 agonists also see a small uptick in resting heart rate. Stack all three of those together and a 9:02 pace suddenly feels like a 10K race effort.
There was also a timing issue I didn’t appreciate early on. I had been dosing on Wednesday evenings, which meant Thursday mornings were peak plasma concentration for the week. The GI side effects, the appetite suppression, the mild nausea at that early stage of titration: all of it was at its strongest exactly when I was lacing up for that Thursday run. Moving the dose to Friday evening (after talking with my prescriber) meant the Thursday run landed at a lower point in the weekly cycle. Small scheduling change, big difference in how the workout felt.
The broader fix was boring. A real pre-workout meal (carbs and some protein, nothing fancy) restored most of the capacity. Adequate fluids with electrolytes handled the rest. Within three weeks of building those habits, my steady-state numbers were back to baseline. The body hadn’t broken. I just needed to feed it differently.
I started keeping a simple log: pre-workout meal time, meal content, fluid intake, and then the workout metrics from my watch. The pattern was unmistakable. Days when I ate a banana with peanut butter and a glass of water with electrolytes 60 to 90 minutes before running, my heart rate stayed in zone two at my normal pace. Days when I skipped that meal because I “wasn’t hungry,” I was in zone four before the second mile. The data made it impossible to cheat.
The Lean Mass Problem Nobody Warns You About Loudly Enough
Months two through four were when the strength training question got serious. The published clinical literature on GLP-1 therapy has discussed this extensively: a meaningful share of the weight that comes off in the early phase can be lean mass, not just fat. A 2021 analysis of the STEP 1 trial data indicated that roughly 39% of total weight lost was lean mass in the semaglutide group, a proportion consistent with what’s seen in calorie-restriction studies more broadly (Wilding et al., New England Journal of Medicine, 2021). The interventions that protect lean mass are well established. Protein intake and resistance training. That’s the list.
I had been a casual gym-goer before starting, hitting the weights maybe twice a week with no real structure. Not enough. The combination of a significant calorie deficit and an inadequate strength stimulus was producing a body composition I could see in the mirror. My arms looked smaller. My legs felt weaker on hills. The labs started reflecting it too.
The specific numbers were sobering. At my month-three DEXA scan, I had lost 14 pounds total: roughly 8 pounds of fat and close to 6 pounds of lean tissue. That’s a lean mass loss ratio that tracks almost exactly with the STEP 1 data and is exactly the outcome that structured resistance training is designed to prevent. Seeing the numbers on the scan report was the wake-up call.
Month four is when I got honest with myself and committed to a structured three-day-a-week strength program. Major compound lifts. Squats, deadlifts, presses, rows, pull-ups. Simple rotation. Protein target of roughly a gram per pound of goal body weight, which meant a daily whey shake because hitting that number on a suppressed appetite is genuinely hard.
The practical challenge of protein on a suppressed appetite deserves its own paragraph. At my caloric intake during months two through four, I was eating roughly 1,400 to 1,600 calories a day without trying. Hitting 160 grams of protein inside that caloric window means almost every meal has to be protein-forward. Chicken breast, Greek yogurt, egg whites, whey, cottage cheese: these became the staples. I ate very little that didn’t have a protein purpose. It felt monotonous, but the alternative was watching my lean mass continue to erode.
The program was a basic linear progression (the kind of program you’ll find in any credible strength training resource). The provider I was working with, this compounding pharmacy, shared similar framing in their patient materials, which helped confirm I wasn’t overthinking it.
Months Five Through Twelve: Where It Actually Started Working
Here’s where the story gets good. By month five, the cardiovascular capacity was back to baseline and, on most metrics, slightly better. The strength training was producing measurable gains. Slower than the gains I’d seen earlier in my training history (calorie deficit will do that), but real. Clearly trending upward.
The body composition part surprised me most. Scale weight was lower than before medication. Lean mass was holding or slightly increasing. I looked different than someone who’d simply lost the same number of pounds through dieting alone, and that difference was entirely attributable to the resistance work and the protein.
A follow-up DEXA at month eight told the story clearly. From month three to month eight, I had lost another 9 pounds. But this time, roughly 8 of those pounds were fat and only about 1 pound was lean tissue. Same medication, same dose, same general caloric range. The variable that changed was the structured strength work and the protein commitment. The contrast with the first three months was dramatic.
If I were describing this to someone starting the medication tomorrow, I’d frame it this way: the first three months are a transition period. Your cardio dips and recovers. Your strength training matters more than it ever has. Your protein intake matters more. Your hydration matters more. By month five, you’ve found your groove, and the work starts producing visible results.
What the Research Actually Shows
The published literature on exercise during GLP-1 therapy supports a few specific claims. Resistance training during the weight-loss phase protects lean mass to a meaningful degree. Adequate protein intake is necessary for that resistance training to do its job (you can’t outwork bad nutrition, even on medication). Cardiovascular training is well tolerated by most patients once the early-phase adjustments for appetite, hydration, and fueling are sorted out.
Research suggests that patients who add a structured resistance training program during the loss phase have better body-composition outcomes at twelve months than patients who skip it. A 2022 study in Nature Medicine examining the STEP 3 trial noted that the lifestyle intervention group (which included structured physical activity) saw improved body composition metrics compared to medication alone (Wadden et al., 2022). The effect size is significant enough that most prescribers will bring up the resistance training conversation in the first few visits. If yours doesn’t, bring it up yourself.
There is also emerging interest in whether GLP-1 agonists affect recovery from exercise. Preclinical data has suggested anti-inflammatory properties associated with the GLP-1 receptor pathway, though the clinical relevance for exercise recovery in humans remains unclear. Anecdotally, my delayed-onset muscle soreness didn’t feel notably different on the medication. The bigger recovery variable, by far, was whether I ate enough protein and carbohydrate after the session.
Three Mistakes I’d Undo If I Could
Mistake one: assuming the medication would do most of the work. It does meaningful work on appetite and caloric intake. The work of building or holding lean mass remains entirely with you. Strength training isn’t optional if the goal is a body composition you actually want to maintain in year two.
Mistake two: undereating around training. The suppressed appetite makes it stupidly easy to skip the pre-workout meal. But skipping that meal produces a worse workout, and a worse workout produces a worse training adaptation. It compounds. Eat on schedule even when you don’t feel like it. Especially when you don’t feel like it.
Mistake three: going too hard on cardio in month one. The early dip in cardiovascular capacity is real, and trying to push through it with intensity just made me feel terrible and recover poorly. The first month is better spent at moderate intensity. Bring the harder intervals back in months two and three, when your fueling habits have caught up.
What My Routine Looks Like Now
Month twelve. Three strength sessions a week on the major compound lifts (still linear progression, still simple). Two moderate cardiovascular sessions, thirty minutes each. A daily walk, roughly thirty minutes, mostly for the mood and metabolic benefits rather than calorie burn. Think of the walks like brushing your teeth. Not exciting, but the cumulative effect is enormous.
The routine is sustainable. It has produced measurable improvements in body composition, strength, and cardiovascular capacity over nine months. It’s also the routine I expect to carry into the maintenance phase, with minor adjustments for the slightly higher calorie intake that maintenance will allow.
Frequently Asked Questions
Can I keep doing HIIT on semaglutide? Yes, but probably not in the first month. High-intensity interval training demands readily available glycogen, and your glycogen stores are likely lower due to reduced food intake. Once your pre-workout fueling habits are dialed in (usually by month two or three), HIIT is fine for most patients. Start back with shorter intervals and build up.
How much protein do I actually need? The commonly cited target for lean mass preservation during a calorie deficit is 0.7 to 1.0 grams per pound of goal body weight per day. On a suppressed appetite, hitting the higher end of that range requires deliberate planning. Protein shakes, high-protein snacks, and protein-forward meals at every sitting are usually necessary.
Will I lose muscle no matter what? Some lean mass loss during significant weight loss is nearly universal, even with optimal training and nutrition. The goal of resistance training and adequate protein is to minimize that loss, not eliminate it entirely. The difference between structured and unstructured approaches is substantial, as my own DEXA data showed.
Should I change my workout timing relative to my dose? This is worth discussing with your prescriber. Many patients find that scheduling harder workouts two to four days after injection, rather than the day after, reduces the overlap between peak medication side effects and exercise demands. I moved my dose to Friday evening so my hardest training days (Monday and Wednesday) fell in a more comfortable window.
Is walking enough, or do I need structured exercise? Walking is valuable for metabolic health, mood, and daily energy expenditure. It is not sufficient to protect lean mass during a significant calorie deficit. You need resistance training with progressive overload for that. Walking and strength training serve different purposes, and both belong in the plan.
What if I feel nauseous during exercise? GI symptoms, including nausea, are common in the early weeks and during dose increases. If nausea hits during a workout, stop and hydrate. Consider reducing exercise intensity around dose-escalation weeks. Eating a small, low-fat meal well before training (90 minutes or more) can help. If nausea during exercise persists beyond the first few weeks at a stable dose, bring it up with your prescriber.
Does semaglutide affect how fast I recover between sessions? The biggest recovery variable for most patients is nutrition, not the medication itself. If you’re eating enough protein and carbohydrate after training, recovery should be roughly normal. If you’re underfueling (which is easy to do when appetite is suppressed), recovery will suffer. Track your post-workout nutrition the same way you track your workouts.
The Honest Summary
Exercise on semaglutide is not the same as exercise before semaglutide. The cardio needs adjustment for changed fueling and hydration. The strength training matters more than it ever did. The protein intake matters more than it ever did. The patient who builds a structured exercise routine in the first four months tends to have a meaningfully better outcome at month twelve than the patient who leans on the medication alone.
The medication is a powerful tool. But it’s a tool, not a replacement for the work. That distinction made all the difference for me.
